These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 21628312)

  • 21. B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department.
    Bassan R; Tura BR; Maisel AS
    Coron Artery Dis; 2009 Mar; 20(2):143-9. PubMed ID: 19293713
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive role of BNP and NT-proBNP in hemodialysis patients.
    Sun L; Sun Y; Zhao X; Xu C; Chen D; Li L; Ma Y; Rong S; Mei C
    Nephron Clin Pract; 2008; 110(3):c178-84. PubMed ID: 18957868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus.
    Bhalla MA; Chiang A; Epshteyn VA; Kazanegra R; Bhalla V; Clopton P; Krishnaswamy P; Morrison LK; Chiu A; Gardetto N; Mudaliar S; Edelman SV; Henry RR; Maisel AS
    J Am Coll Cardiol; 2004 Sep; 44(5):1047-52. PubMed ID: 15337217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association between cardiac biomarkers and the development of ESRD in patients with type 2 diabetes mellitus, anemia, and CKD.
    Desai AS; Toto R; Jarolim P; Uno H; Eckardt KU; Kewalramani R; Levey AS; Lewis EF; McMurray JJ; Parving HH; Solomon SD; Pfeffer MA
    Am J Kidney Dis; 2011 Nov; 58(5):717-28. PubMed ID: 21820220
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.
    Christ M; Laule-Kilian K; Hochholzer W; Klima T; Breidthardt T; Perruchoud AP; Mueller C
    J Am Coll Cardiol; 2006 Nov; 48(9):1808-12. PubMed ID: 17084254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of the prognostic usefulness of N-terminal pro-brain natriuretic Peptide in patients with heart failure with versus without chronic kidney disease.
    Bruch C; Fischer C; Sindermann J; Stypmann J; Breithardt G; Gradaus R
    Am J Cardiol; 2008 Aug; 102(4):469-74. PubMed ID: 18678308
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-type natriuretic peptide and the risk of cardiovascular events and death in patients with stable angina: results from the AtheroGene study.
    Schnabel R; Lubos E; Rupprecht HJ; Espinola-Klein C; Bickel C; Lackner KJ; Cambien F; Tiret L; Münzel T; Blankenberg S
    J Am Coll Cardiol; 2006 Feb; 47(3):552-8. PubMed ID: 16458135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Plasma natriuretic peptides up to 2 years after acute myocardial infarction and relation to prognosis: an OPTIMAAL substudy.
    Squire IB; Ørn S; Ng LL; Manhenke C; Shipley L; Aarsland T; Dickstein K
    J Card Fail; 2005 Sep; 11(7):492-7. PubMed ID: 16198243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease.
    Richards M; Nicholls MG; Espiner EA; Lainchbury JG; Troughton RW; Elliott J; Frampton CM; Crozier IG; Yandle TG; Doughty R; MacMahon S; Sharpe N; ;
    J Am Coll Cardiol; 2006 Jan; 47(1):52-60. PubMed ID: 16386664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Usefulness of N-terminal pro-brain natriuretic peptide to predict postoperative cardiac complications and long-term mortality after emergency lower limb orthopedic surgery.
    Chong CP; Ryan JE; van Gaal WJ; Lam QT; Sinnappu RN; Burrell LM; Savige J; Lim WK
    Am J Cardiol; 2010 Sep; 106(6):865-72. PubMed ID: 20816130
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH; Bax JJ; Elhendy A; de Jonge R; Lindemans J; Schouten O; van den Meiracker AH; Boersma E; Schinkel AF; Kertai MD; van Sambeek MR; Poldermans D
    Am J Cardiol; 2006 Jul; 98(1):111-5. PubMed ID: 16784932
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D; Schouten O; Boersma E; Welten GM; Dunkelgrun M; Lindemans J; van Gestel YR; Hoeks SE; Bax JJ; Poldermans D
    Am J Cardiol; 2008 Jan; 101(1):122-6. PubMed ID: 18157978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B-type natriuretic peptide in the early diagnosis and risk stratification of acute chest pain.
    Haaf P; Reichlin T; Corson N; Twerenbold R; Reiter M; Steuer S; Bassetti S; Winkler K; Stelzig C; Heinisch C; Drexler B; Freidank H; Mueller C
    Am J Med; 2011 May; 124(5):444-52. PubMed ID: 21531234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of B-type natriuretic peptide in diagnosing left ventricular dysfunction in dialysis-dependent patients.
    Zeng C; Wei T; Jin L; Wang L
    Intern Med J; 2006 Sep; 36(9):552-7. PubMed ID: 16911545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Usefulness of natriuretic Peptide levels to predict mortality in adults with congenital heart disease.
    Giannakoulas G; Dimopoulos K; Bolger AP; Tay EL; Inuzuka R; Bedard E; Davos C; Swan L; Gatzoulis MA
    Am J Cardiol; 2010 Mar; 105(6):869-73. PubMed ID: 20211335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of B-Type natriuretic peptides in patients with stable coronary artery disease: the PEACE Trial.
    Omland T; Sabatine MS; Jablonski KA; Rice MM; Hsia J; Wergeland R; Landaas S; Rouleau JL; Domanski MJ; Hall C; Pfeffer MA; Braunwald E;
    J Am Coll Cardiol; 2007 Jul; 50(3):205-14. PubMed ID: 17631211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic value of cardiac biomarkers for death in a non-dialysis chronic kidney disease population.
    Vickery S; Webb MC; Price CP; John RI; Abbas NA; Lamb EJ
    Nephrol Dial Transplant; 2008 Nov; 23(11):3546-53. PubMed ID: 18562472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A preliminary report on the prognostic significance of preoperative brain natriuretic peptide and postoperative cardiac troponin in patients undergoing major vascular surgery.
    Bolliger D; Seeberger MD; Lurati Buse GA; Christen P; Rupinski B; Gürke L; Filipovic M
    Anesth Analg; 2009 Apr; 108(4):1069-75. PubMed ID: 19299763
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NT-proBNP, fluid volume overload and dialysis modality are independent predictors of mortality in ESRD patients.
    Paniagua R; Ventura MD; Avila-Díaz M; Hinojosa-Heredia H; Méndez-Durán A; Cueto-Manzano A; Cisneros A; Ramos A; Madonia-Juseino C; Belio-Caro F; García-Contreras F; Trinidad-Ramos P; Vázquez R; Ilabaca B; Alcántara G; Amato D
    Nephrol Dial Transplant; 2010 Feb; 25(2):551-7. PubMed ID: 19679559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis.
    Suzuki S; Yoshimura M; Nakayama M; Mizuno Y; Harada E; Ito T; Nakamura S; Abe K; Yamamuro M; Sakamoto T; Saito Y; Nakao K; Yasue H; Ogawa H
    Circulation; 2004 Sep; 110(11):1387-91. PubMed ID: 15353502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.